118 related articles for article (PubMed ID: 9617488)
1. Immunohistochemical study of human advanced glycation end-products (AGE) and growth factors in cardiac tissues of patients on maintenance dialysis and with kidney transplantation.
Yoshida S; Yamada K; Hamaguchi K; Nishimura M; Hatakeyama E; Tsuchida H; Sakamoto K; Kashiwabara H; Yokoyama T; Ikeda K; Horiuchi S
Clin Nephrol; 1998 May; 49(5):273-80. PubMed ID: 9617488
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical distribution and subcellular localization of three distinct specific molecular structures of advanced glycation end products in human tissues.
Ling X; Sakashita N; Takeya M; Nagai R; Horiuchi S; Takahashi K
Lab Invest; 1998 Dec; 78(12):1591-606. PubMed ID: 9881959
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of human advanced glycosylation end-products (AGE) in chronic renal failure.
Yamada K; Miyahara Y; Hamaguchi K; Nakayama M; Nakano H; Nozaki O; Miura Y; Suzuki S; Tuchida H; Mimura N
Clin Nephrol; 1994 Dec; 42(6):354-61. PubMed ID: 7882598
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of advanced glycation end products, measured as skin autofluorescence, in renal disease.
Hartog JW; de Vries AP; Lutgers HL; Meerwaldt R; Huisman RM; van Son WJ; de Jong PE; Smit AJ
Ann N Y Acad Sci; 2005 Jun; 1043():299-307. PubMed ID: 16037252
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of advanced glycation end products in children with renal disease.
Sebeková K; Podracká L; Blazícek P; Syrová D; Heidland A; Schinzel R
Pediatr Nephrol; 2001 Dec; 16(12):1105-12. PubMed ID: 11793110
[TBL] [Abstract][Full Text] [Related]
6. Enhanced plasma levels of advanced glycation end products (AGE) and pro-inflammatory cytokines in children/adolescents with chronic renal insufficiency and after renal replacement therapy by dialysis and transplantation--are they inter-related?
Sebeková K; Podracká L; Heidland A; Schinzel R
Clin Nephrol; 2001 Dec; 56(6):S21-6. PubMed ID: 11770807
[TBL] [Abstract][Full Text] [Related]
7. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
Busch M; Franke S; Wolf G; Brandstädt A; Ott U; Gerth J; Hunsicker LG; Stein G;
Am J Kidney Dis; 2006 Oct; 48(4):571-9. PubMed ID: 16997053
[TBL] [Abstract][Full Text] [Related]
8. Nepsilon-(carboxymethyl)lysine, Nepsilon-(carboxyethyl)lysine and vascular cell adhesion molecule-1 (VCAM-1) in relation to peritoneal glucose prescription and residual renal function; a study in peritoneal dialysis patients.
van de Kerkhof J; Schalkwijk CG; Konings CJ; Cheriex EC; van der Sande FM; Scheffer PG; ter Wee PM; Leunissen KM; Kooman JP
Nephrol Dial Transplant; 2004 Apr; 19(4):910-6. PubMed ID: 15031349
[TBL] [Abstract][Full Text] [Related]
9. Detection of N epsilon-(carboxymethyl)lysine (CML) and non-CML advanced glycation end-products in the anterior horn of amyotrophic lateral sclerosis spinal cord.
Kikuchi S; Shinpo K; Ogata A; Tsuji S; Takeuchi M; Makita Z; Tashiro K
Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Jun; 3(2):63-8. PubMed ID: 12215227
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome after coronary angioplasty in renal transplant and hemodialysis patients.
Borentain M; Le Feuvre C; Helft G; Beygui F; Batisse JP; Drobinski G; Metzger JP
J Interv Cardiol; 2005 Oct; 18(5):331-7. PubMed ID: 16202107
[TBL] [Abstract][Full Text] [Related]
11. Low-molecular but not high-molecular advanced glycation end products (AGEs) are removed by high-flux dialysis.
Gerdemann A; Lemke HD; Nothdurft A; Heidland A; Münch G; Bahner U; Schinzel R
Clin Nephrol; 2000 Oct; 54(4):276-83. PubMed ID: 11076103
[TBL] [Abstract][Full Text] [Related]
12. Renal N(epsilon)-carboxymethyllysine deposition after kidney transplantation.
Baumann M; Caron M; Schmaderer C; Schulte C; Viklicky O; von Weyhern CW; Lutz J; Heemann U
Transplantation; 2008 Jul; 86(2):330-5. PubMed ID: 18645498
[TBL] [Abstract][Full Text] [Related]
13. An inhibitor of advanced glycation end product formation reduces N epsilon-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats.
Nakamura S; Tachikawa T; Tobita K; Aoyama I; Takayama F; Enomoto A; Niwa T
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S68-71. PubMed ID: 12612956
[TBL] [Abstract][Full Text] [Related]
14. Expression of advanced glycation end products and their receptor in skin from patients with systemic sclerosis with and without calcinosis.
Davies CA; Herrick AL; Cordingley L; Freemont AJ; Jeziorska M
Rheumatology (Oxford); 2009 Aug; 48(8):876-82. PubMed ID: 19542215
[TBL] [Abstract][Full Text] [Related]
15. Clinical and prognostic value of advanced glycation end-products in chronic heart failure.
Hartog JW; Voors AA; Schalkwijk CG; Scheijen J; Smilde TD; Damman K; Bakker SJ; Smit AJ; van Veldhuisen DJ
Eur Heart J; 2007 Dec; 28(23):2879-85. PubMed ID: 17986469
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of advanced glycation end products and chronic complications in ESRD treated by dialysis.
Meerwaldt R; Zeebregts CJ; Navis G; Hillebrands JL; Lefrandt JD; Smit AJ
Am J Kidney Dis; 2009 Jan; 53(1):138-50. PubMed ID: 19036487
[TBL] [Abstract][Full Text] [Related]
17. Successful renal transplantation decreases aortic stiffness and increases vascular reactivity in dialysis patients.
Covic A; Goldsmith DJ; Gusbeth-Tatomir P; Buhaescu I; Covic M
Transplantation; 2003 Dec; 76(11):1573-7. PubMed ID: 14702526
[TBL] [Abstract][Full Text] [Related]
18. N(epsilon)-(carboxymethyl)lysine depositions in intramyocardial blood vessels in human and rat acute myocardial infarction: a predictor or reflection of infarction?
Baidoshvili A; Krijnen PA; Kupreishvili K; Ciurana C; Bleeker W; Nijmeijer R; Visser CA; Visser FC; Meijer CJ; Stooker W; Eijsman L; van Hinsbergh VW; Hack CE; Niessen HW; Schalkwijk CG
Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2497-503. PubMed ID: 16973974
[TBL] [Abstract][Full Text] [Related]
19. [The comparison of selected parameters of structure and function of the cardiovascular system in patients with functioning graft on maintenance hemodialysis during a one year period].
Króliczak M; Stompór T; Sułowicz W; Ochmański W; Królczyk J
Przegl Lek; 2001; 58(10):894-902. PubMed ID: 11957815
[TBL] [Abstract][Full Text] [Related]
20. Kidney transplantation decreases the tissue level of advanced glycosylation end-products.
Lee WK; Akyol M; Shaw S; Dominiczak MH; Briggs JD
Nephrol Dial Transplant; 1995; 10(1):103-7. PubMed ID: 7724002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
